Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
4.76%
End price
30.07.24
€5.50
Summary
This prediction ended on 30.07.24 with a price of €5.50. With a performance of 4.76%, the BUY prediction by StockNews_com for Vanda Pharmaceuticals closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | -9.639% | -9.639% | 60.944% |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten